To analyze the real situation of intravenous thrombolysis in acute ischemic stroke in China
Compare the efficacy and safety of different thrombolytic drugs; Analysis of patients during hospital treatment of adverse events and complications; Analysis of factors that affect the effectiveness of treatment; Evaluate the pharmacological benefits of different thrombolytic drugs
Study Type
OBSERVATIONAL
General Hospital of Shenyang Military Region
Shenyang, Liaoning, China
mRS of 90 days after thrombolysis
Proportion of patients with mRS = 0-1 points 90 days after thrombolysis
Time frame: Month 3
Evaluation of Adverse events
Symptomatic intracranial hemorrhage conversion rate; Liver and kidney dysfunction; Bleeding gums; Skin mucous membrane bleeding
Time frame: Year 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.